263 related articles for article (PubMed ID: 11881232)
21. [Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal].
Patricio LD; Miguel N
Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():28-30. PubMed ID: 7880010
[No Abstract] [Full Text] [Related]
22. Retention in naltrexone implant treatment for opioid dependence.
Kunøe N; Lobmaier P; Vederhus JK; Hjerkinn B; Hegstad S; Gossop M; Kristensen O; Waal H
Drug Alcohol Depend; 2010 Sep; 111(1-2):166-9. PubMed ID: 20570059
[TBL] [Abstract][Full Text] [Related]
23. Excess mortality among opioid-using patients treated with oral naltrexone in Australia.
Degenhardt L; Larney S; Kimber J; Farrell M; Hall W
Drug Alcohol Rev; 2015 Jan; 34(1):90-6. PubMed ID: 25302627
[TBL] [Abstract][Full Text] [Related]
24. Regarding naltrexone for probationers and parolees.
Stancliff S
J Subst Abuse Treat; 2007 Mar; 32(2):217-8; author reply 218-9. PubMed ID: 17306730
[No Abstract] [Full Text] [Related]
25. Does naltrexone affect craving in abstinent opioid-dependent patients?
Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP
Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990
[TBL] [Abstract][Full Text] [Related]
26. Can psychotherapy rescue naltrexone treatment of opioid addiction?
Rounsaville BJ
NIDA Res Monogr; 1995; 150():37-52. PubMed ID: 8742771
[No Abstract] [Full Text] [Related]
27. Quality of life among heroin users on buprenorphine versus methadone maintenance.
Ponizovsky AM; Grinshpoon A
Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
[TBL] [Abstract][Full Text] [Related]
28. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
[TBL] [Abstract][Full Text] [Related]
29. Naltrexone implants as treatment for heroin dependence: part I.
Byrne A; Graham G; Hallinan R; Murnion B
Addict Biol; 2005 Jun; 10(2):201; author reply 201-2. PubMed ID: 16191674
[No Abstract] [Full Text] [Related]
30. Long-acting depot formulations of naltrexone for heroin dependence: a review.
Krupitsky EM; Blokhina EA
Curr Opin Psychiatry; 2010 May; 23(3):210-4. PubMed ID: 20224403
[TBL] [Abstract][Full Text] [Related]
31. Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?
Nunes EV; Rothenberg JL; Sullivan MA; Carpenter KM; Kleber HD
Am J Drug Alcohol Abuse; 2006; 32(4):503-17. PubMed ID: 17127538
[TBL] [Abstract][Full Text] [Related]
32. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
Buntwal N; Bearn J; Gossop M; Strang J
Drug Alcohol Depend; 2000 May; 59(2):183-8. PubMed ID: 10891632
[TBL] [Abstract][Full Text] [Related]
33. Biological correlates of methadone maintenance pharmacotherapy.
Kreek MJ
Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():9-14. PubMed ID: 7880038
[No Abstract] [Full Text] [Related]
34. Commentary on Krupitsky et al.(2013): Refuge from the streets--parked on methadone, or seeking shelter of a depot?
Bell J
Addiction; 2013 Sep; 108(9):1638-9. PubMed ID: 23947734
[No Abstract] [Full Text] [Related]
35. Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.
Gerra G; Zaimovic A; Rustichelli P; Fontanesi B; Zambelli U; Timpano M; Bocchi C; Delsignore R
J Subst Abuse Treat; 2000 Mar; 18(2):185-91. PubMed ID: 10716102
[TBL] [Abstract][Full Text] [Related]
36. Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy.
Chen TJ; Blum K; Payte JT; Schoolfield J; Hopper D; Stanford M; Braverman ER
Med Hypotheses; 2004; 63(3):538-48. PubMed ID: 15288384
[TBL] [Abstract][Full Text] [Related]
37. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP;
Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745
[TBL] [Abstract][Full Text] [Related]
38. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction.
Simon DL
Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434
[No Abstract] [Full Text] [Related]
39. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
Holtzman SG
J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C treatment, subcutaneous naltrexone implants, and methadone maintenance treatment.
Novick DM; Kreek MJ
Hepatology; 2007 Sep; 46(3):951-2. PubMed ID: 17705265
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
